Drug Type Bispecific antibody |
Synonyms- |
Target |
Action agonists |
Mechanism CD94 agonists(killer cell lectin like receptor D1 agonists), TCR agonists(T-cell receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Lung Non-Small Cell Carcinoma | Preclinical | China | 26 Jun 2025 |